Soluble human complement receptor type 1 inhibits complement-mediated host defense.
Soluble complement receptor type 1 (sCR1) is a powerful inhibitor of complement activation. Because of this ability, sCR1 may prove to be an important therapeutic agent that can be used to block the immunopathologic effects of uncontrolled complement activation in a variety of clinically significant...
সংরক্ষণ করুন:
| প্রকাশিত: | Clin Diagn Lab Immunol |
|---|---|
| প্রধান লেখক: | , , , |
| বিন্যাস: | Artigo |
| ভাষা: | Inglês |
| প্রকাশিত: |
American Society for Microbiology (ASM)
1994
|
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC368344/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8556505/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/cdli.1.5.585-589.1994 |
| ট্যাগগুলো: |
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|